337 related articles for article (PubMed ID: 33061527)
1. Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
Dhaiban S; Al-Ani M; Elemam NM; Maghazachi AA
J Inflamm Res; 2020; 13():619-633. PubMed ID: 33061527
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis.
Ghafouri-Fard S; Honarmand K; Taheri M
Metab Brain Dis; 2021 Mar; 36(3):375-406. PubMed ID: 33404937
[TBL] [Abstract][Full Text] [Related]
3. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G
Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436
[TBL] [Abstract][Full Text] [Related]
4. The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.
Scheu S; Ali S; Ruland C; Arolt V; Alferink J
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099057
[TBL] [Abstract][Full Text] [Related]
5. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.
Szczuciński A; Losy J
Acta Neurol Scand; 2007 Mar; 115(3):137-46. PubMed ID: 17295707
[TBL] [Abstract][Full Text] [Related]
6. Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression.
Fischer FR; Santambrogio L; Luo Y; Berman MA; Hancock WW; Dorf ME
J Neuroimmunol; 2000 Oct; 110(1-2):195-208. PubMed ID: 11024550
[TBL] [Abstract][Full Text] [Related]
7. Chemokines and chemokine receptors in autoimmune encephalomyelitis as a model for central nervous system inflammatory disease regulation.
Dogan RN; Karpus WJ
Front Biosci; 2004 May; 9():1500-5. PubMed ID: 14977561
[TBL] [Abstract][Full Text] [Related]
8. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice.
Dos Santos AC; Roffê E; Arantes RM; Juliano L; Pesquero JL; Pesquero JB; Bader M; Teixeira MM; Carvalho-Tavares J
J Neuroinflammation; 2008 Nov; 5():49. PubMed ID: 18986535
[TBL] [Abstract][Full Text] [Related]
9. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE.
Adamus G; Manczak M; Machnicki M
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2894-903. PubMed ID: 11687534
[TBL] [Abstract][Full Text] [Related]
10. Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets.
Czaja AJ
Aliment Pharmacol Ther; 2014 Aug; 40(3):261-79. PubMed ID: 24890045
[TBL] [Abstract][Full Text] [Related]
11. Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis.
Bielecki B; Jatczak-Pawlik I; Wolinski P; Bednarek A; Glabinski A
Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):367-76. PubMed ID: 25957582
[TBL] [Abstract][Full Text] [Related]
12. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
[TBL] [Abstract][Full Text] [Related]
13. Involvement of beta-chemokines in the development of inflammatory demyelination.
Banisor I; Leist TP; Kalman B
J Neuroinflammation; 2005 Feb; 2(1):7. PubMed ID: 15730561
[TBL] [Abstract][Full Text] [Related]
14. Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors.
Kan QC; Pan QX; Zhang XJ; Chu YJ; Liu N; Lv P; Zhang GX; Zhu L
Exp Mol Pathol; 2015 Oct; 99(2):212-9. PubMed ID: 26093163
[TBL] [Abstract][Full Text] [Related]
15. The presence of cerebellar B cell aggregates is associated with a specific chemokine profile in the cerebrospinal fluid in a mouse model of multiple sclerosis.
Schropp V; Chunder R; Dietel B; Tacke S; Kuerten S
J Neuroinflammation; 2023 Jan; 20(1):18. PubMed ID: 36717913
[TBL] [Abstract][Full Text] [Related]
16. Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis.
Glabinski AR; Krakowski M; Han Y; Owens T; Ransohoff RM
J Neurovirol; 1999 Feb; 5(1):95-101. PubMed ID: 10190695
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis.
Alt C; Laschinger M; Engelhardt B
Eur J Immunol; 2002 Aug; 32(8):2133-44. PubMed ID: 12209625
[TBL] [Abstract][Full Text] [Related]
18. CC Chemokine Family Members' Modulation as a Novel Approach for Treating Central Nervous System and Peripheral Nervous System Injury-A Review of Clinical and Experimental Findings.
Ciechanowska A; Mika J
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612597
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.
Mecha M; Feliú A; Iñigo PM; Mestre L; Carrillo-Salinas FJ; Guaza C
Neurobiol Dis; 2013 Nov; 59():141-50. PubMed ID: 23851307
[TBL] [Abstract][Full Text] [Related]
20. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
